Pulse nav.journalClub Debates ativos Tendências Explorar Pesquisadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidade

Início Explorar nav.journalClub Tendências

⌘+K

Can tenascin - X be a marker of bone turnover in patients with Ehlers-Danlos syndrome? | Synapse

May 6, 2024

Can tenascin - X be a marker of bone turnover in patients with Ehlers-Danlos syndrome?

Key Points

Key points are not available for this paper at this time.

Abstract

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Perguntar à IA

Like

Bookmark

Share

Perguntar à IA

Like

Bookmark

Share

Cite This Study

Żuk et al. (Mon,) studied this question.

synapsesocial.com/papers/68e6b6e1b6db643587637f90 https://doi.org/https://doi.org/10.1530/endoabs.99.ep750

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Does tenascin-X correlate with adrenal dysfunction in patients with Ehlers-Danlos syndrome?2024
2Vitamin D deficiency in patients with Ehlers-Danlos syndrome2024
3Is autoimmune thyroiditis in females with Ehlers-Danlos syndrome associated with lower bone density?2024
4The effects of obesity on bone mineral density in women with Ehlers-Danlos syndrome2024
5Is autoimmune thyroiditis in females with ehlers-danlos syndrome associated with lower bone density?2024